Compass Therapeutics, Inc.: Form 8-K, filed Mar 5, 2026
Filed with the SEC on Mar 5, 2026 and accepted by EDGAR at Mar 5, 2026, 12:30 ET.
Items reported
- Item 2.02 Results of operations
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001171843-26-001336. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.